Literature DB >> 14526427

Effect of levodopa chronic administration on behavioral changes and fos expression in basal ganglia in rat model of PD.

Yan Xu1, Shenggang Sun, Xuebing Cao.   

Abstract

To study behavioral character and changes of neuronal activity in the basal ganglia of rat model of levodopa-induced dyskinesia, unilateral 6-hydroxydopamine lesioned rat model of Parkinson disease (PD) was treated with levodopa/benserazide twice daily for 4 weeks and the behavior observed on the 1st, 3rd, 4th, 7th, 9th, 10th, 14th, 21st and 28th day. The animals were sacrificed and immunohistochemical technique was used to measure the changes of Fos expression in the caudate putamen (CPU), globus pallidus (GP) and sensorimotor area of cerebral cortex 2 h after the last treatment. The results showed that pulsatile treatment with a subthreshold dose of levodopa gradually induced abnormal involuntary movement (AIM), including stereotypy (limb dyskinesia, axial dystonia and masticatory dyskinesia) towards the side contralateral to the dopamine-denervated striatum and increased contraversive rotation. The motor pattern of each subtype was highly stereotypic across individual rats, and the proportion of each subtype was not consistent among individual rats. Fos positive nuclei in the CPU and GP were increased by levodopa acute administration, and more remarkably in the CPU, but not in the cerebral cortex. After repeated levodopa treatment. Fos positive nuclei were reduced remarkably in the CPU, but were increased in the GP and cerebral cortex. It was concluded that the neural mechanisms underlying levodopa induced AIM in rat model of PD was very similar to those seen in levodopa-induced dyskinesia (LID) in PD patients and MPTP-lesioned monkeys, and increased striatopallidal neuronal activity might be involved in occurrence of LID.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14526427     DOI: 10.1007/bf02829507

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

1.  Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits.

Authors:  J D Oh; C L Vaughan; T N Chase
Journal:  Brain Res       Date:  1999-03-13       Impact factor: 3.252

2.  Mu- and delta-opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease.

Authors:  B Henry; S H Fox; A R Crossman; J M Brotchie
Journal:  Exp Neurol       Date:  2001-09       Impact factor: 5.330

3.  Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade.

Authors:  S M Papa; R C Boldry; T M Engber; A M Kask; T N Chase
Journal:  Brain Res       Date:  1995-12-01       Impact factor: 3.252

4.  Embryonic ventral mesencephalic grafts improve levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Authors:  C S Lee; M A Cenci; M Schulzer; A Björklund
Journal:  Brain       Date:  2000-07       Impact factor: 13.501

5.  Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test.

Authors:  M Olsson; G Nikkhah; C Bentlage; A Björklund
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

6.  Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

Authors:  B Henry; A R Crossman; J M Brotchie
Journal:  Exp Neurol       Date:  1998-06       Impact factor: 5.330

7.  A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization.

Authors:  J Thomas; J Wang; H Takubo; J Sheng; S de Jesus; K S Bankiewicz
Journal:  Exp Neurol       Date:  1994-04       Impact factor: 5.330

8.  Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys.

Authors:  S M Papa; T N Chase
Journal:  Ann Neurol       Date:  1996-05       Impact factor: 10.422

  8 in total
  2 in total

1.  Imbalanced Dopaminergic Transmission Mediated by Serotonergic Neurons in L-DOPA-Induced Dyskinesia.

Authors:  Sylvia Navailles; Philippe De Deurwaerdère
Journal:  Parkinsons Dis       Date:  2011-10-11

2.  Striatal Gαolf/cAMP Signal-Dependent Mechanism to Generate Levodopa-Induced Dyskinesia in Parkinson's Disease.

Authors:  Satoshi Goto
Journal:  Front Cell Neurosci       Date:  2017-11-21       Impact factor: 5.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.